Thursday 4/8 Insider Buying Report: NMTR, JRO

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

On Monday, 9 Meters Biopharma's Chief Financial Officer, Edward J.

Sitar, made a $50,000 buy of NMTR, purchasing 50,000 shares at a cost of $1.00 a piece.

So far Sitar is in the green, up about 24.0% on their purchase based on today's trading high of $1.24.

9 Meters Biopharma is trading down about 3.2% on the day Thursday.

This buy marks the first one filed by Sitar in the past twelve months.

And on Wednesday, Scott C.

Caraher purchased $47,900 worth of Nuveen Floating Rate Income Opportunity Fund, purchasing 5,000 shares at a cost of $9.58 a piece.

Nuveen Floating Rate Income Opportunity Fund is trading up about 0.2% on the day Thursday.

So far Caraher is in the green, up about 0.2% on their buy based on today's trading high of $9.60.